Hancock Whitney’s NEVRO CORP. NVRO Stock Holding History

Hancock Whitney’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,553	Closed	-$255K	–	885
2020 Q1	$255K	Buy	+2,553	New	+$307K	0.01%	686

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Hancock Whitney's NVRO Position: Q2 2020 in Review

Hancock Whitney sold out of NEVRO CORP. (NVRO) in Q2 2020, closing a stake of 2,553 shares — an estimated $255K sold.

Hancock Whitney first reported a position in NVRO in Q1 2020 and held it in 1 quarter. The position peaked at $255K in Q1 2020. 202 funds tracked by Wall St. Rank hold NVRO as of Q2 2020.

Hancock Whitney reported no remaining NEVRO CORP. position as of Q2 2020 after selling out during the quarter.
Hancock Whitney sold 2,553 NEVRO CORP. shares in Q2 2020, an estimated $255K.
Hancock Whitney first reported a position in NEVRO CORP. in Q1 2020 and held it in 1 quarter.
Hancock Whitney's NEVRO CORP. position peaked at $255K in Q1 2020.
202 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2020.

Based on Hancock Whitney's 13F filing for Q2 2020, filed 30 Jul 2020.